GlassScriptPhysician profile
William O Passarelli
NPI 1285653113
$14,742.06
in general payments reported to CMS, 2019-2025
48 companies · $2,277 in 2025
The $2,277 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,762 · 2020: $2,063 · 2021: $2,614 · 2022: $2,458 · 2023: $2,222 · 2024: $1,347 · 2025: $2,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,846.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,297.15 | 2019-2025 | General - Structural Heart, Avvigo Guidance System, Versacross Large Access Solution |
| Novartis Pharmaceuticals Corporation | $1,164.18 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,068.64 | 2019-2024 | Xarelto |
| Medtronic, INC. | $971.43 | 2021-2025 | Micra, Selectsecure, In.Pact Admiral |
| Abbott Laboratories | $924.48 | 2019-2025 | Jot Dx, Aveir, Esprit |
| Amgen INC. | $852.56 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $749.12 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $735.01 | 2021-2025 | Verquvo, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $693.65 | 2019-2023 | Jardiance |
| W. L. Gore & Associates, INC. | $594.09 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Angiodynamics, INC. | $529.81 | 2023 | Alphavac, Auryon Laser System 100-120 Vac |
| Sanofi-Aventis U.S. LLC | $498.58 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $498.21 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $485.18 | 2019-2024 | |
| Bard Peripheral Vascular, INC. | $428.13 | 2020-2021 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $383.27 | 2020-2024 | Nexletol |
| Baxter Healthcare | $305.77 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor |
| Abiomed | $271.51 | 2021-2022 | |
| Cvrx, INC. | $212.93 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $199.10 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $193.37 | 2020-2022 | |
| Scpharmaceuticals INC. | $168.96 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $150.98 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $143.94 | 2020-2025 | Lifevest |
| Biotronik INC. | $142.49 | 2022-2025 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Terumo Medical Corporation | $134.98 | 2021 | |
| Inari Medical, INC. | $125.00 | 2021 | |
| Impulse Dynamics (USA) INC. | $119.93 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $80.83 | 2022-2025 | Uptravi, Opsumit |
| Amarin Pharma, INC. | $61.05 | 2020-2022 | |
| Edwards Lifesciences Corporation | $61.05 | 2025 | Pascal |
| Heartflow, INC. | $60.82 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $58.22 | 2025 | Evkeeza |
| Daiichi Sankyo INC. | $47.18 | 2020-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $47.11 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $44.29 | 2019-2021 | |
| Lundbeck LLC | $35.57 | 2020 | |
| Novo Nordisk INC | $30.04 | 2024-2025 | Wegovy |
| Irhythm Technologies, INC. | $27.58 | 2023 | Zio Xt Patch |
| Alnylam Pharmaceuticals INC. | $27.43 | 2025 | Amvuttra |
| Kiniksa Pharmaceuticals, LTD. | $21.11 | 2021 | |
| Ge Healthcare | $20.05 | 2025 | |
| Cardiovascular Systems INC. | $19.48 | 2022 | |
| Gilead Sciences, INC. | $16.13 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.66 | 2019 | |
| Atricure, INC. | $13.54 | 2022 | |
| Inogen, INC. | $9.24 | 2022 | |
| Zoll Circulation INC | $5.23 | 2023 | Catheter, Therox Ds2 Console, Downstream Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Passarelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.